How different dosing conditions affect HRS9531 in healthy men
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial is testing how different ways of taking an oral medication (HRS9531) affect the drug levels in the body. It is for healthy men to help find the best dosing conditions for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 55 years old.
- You weigh at least 50 kg (110 lbs) and have a BMI between 23 and 35.
- Your weight has been stable (no more than 5 kg change) in the last 3 months.
- You are generally healthy and have no major medical conditions or recent stomach surgery.
- You do not use tobacco or alcohol regularly, and you have no history of drug abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
Hear when a new Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.